The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice

Anuj K. Sharma(Augusta University), Meghan E. McGee‐Lawrence(University of Georgia)
Frontiers in Cell and Developmental Biology
May 20, 2020
Cited by 126


Related Papers